Pages with the fewest revisions

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

1. Gemtuzumab Ozogamicin‏‎ (2 revisions)
2. ICE‏‎ (2 revisions)
3. ICE-aml‏‎ (2 revisions)
4. IFL + Bevacizumab‏‎ (2 revisions)
5. IL-2‏‎ (2 revisions)
6. IMVP-16‏‎ (2 revisions)
7. IVE‏‎ (2 revisions)
8. Ifosfamide‏‎ (2 revisions)
9. Ifosfamide + Paclitaxel‏‎ (2 revisions)
10. HyperCVADHDMTX-AraC‏‎ (2 revisions)
11. HyperCVAD‏‎ (2 revisions)
12. Goserelin‏‎ (2 revisions)
13. Goserelin + Flutamide + RT‏‎ (2 revisions)
14. Guidelines on using this site‏‎ (2 revisions)
15. HAM‏‎ (2 revisions)
16. Hairy Cell Leukemia‏‎ (2 revisions)
17. Hematological Malignancies‏‎ (2 revisions)
18. Hepatocellular Cancer Adult, Primary‏‎ (2 revisions)
19. High dose Methotrexate‏‎ (2 revisions)
20. Imatinib‏‎ (2 revisions)
21. Kaposi's Sarcoma‏‎ (2 revisions)
22. Ketoconazole‏‎ (2 revisions)
23. M-BACOD‏‎ (2 revisions)
24. MACOP-B‏‎ (2 revisions)
25. MAID‏‎ (2 revisions)
26. MCP‏‎ (2 revisions)
27. MIME‏‎ (2 revisions)
28. MINE/ESHAP‏‎ (2 revisions)
29. MOPP‏‎ (2 revisions)
30. MOPPABV Hybrid‏‎ (2 revisions)
31. Luprolide‏‎ (2 revisions)
32. Lung Cancer Small Cell‏‎ (2 revisions)
33. Kidney Renal Cell Cancer‏‎ (2 revisions)
34. LALA‏‎ (2 revisions)
35. LV5FU-P‏‎ (2 revisions)
36. LV + 5-FU + Irinotecan + Bevacizumab‏‎ (2 revisions)
37. Lenalidomide‏‎ (2 revisions)
38. Lenalidomide + Rituximab‏‎ (2 revisions)
39. Linker Regimen‏‎ (2 revisions)
40. Lung Cancer Non Small Cell‏‎ (2 revisions)
41. MP‏‎ (2 revisions)
42. Gemcitabine + Vinorelbine‏‎ (2 revisions)
43. Etoposide + Cisplatin‏‎ (2 revisions)
44. FOLFIRI + Bevacizumab‏‎ (2 revisions)
45. FOLFIRI + Cetuximab‏‎ (2 revisions)
46. FOLFOX‏‎ (2 revisions)
47. FOLFOX4‏‎ (2 revisions)
48. FOLFOX4 + Bevacizumab‏‎ (2 revisions)
49. FOLFOX4 + Cetuximab‏‎ (2 revisions)
50. FOLFOX6‏‎ (2 revisions)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)